A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses

Table 1 Detection of galectin-9 in biopsies from head and neck carcinomas

Patient	Origin	Gender/Age	Tumor site/Histological Type	Clinical stage	Galectin-9 staining
					Malignant cells	Stroma cells	Adjacent mucosa
							(epithelium type)
1	Tunisia	M/48	NPC/UNK*	T4N3bM1	+ +	+	- (malpighian)
2	Romania	F/34	NPC/UNK	T2bN0M0	+ +	+	- (malpighian)
3	Cameroon	M/62	NPC/UNK	T4N2M0	+ +	-	+ (secretory)
4	France	M/63	NPC/UNK	T4N0Mx	+ +	+	n/a
5	France	M/62	NPC/UNK	T3N2M0	+ +	+	n/a
6	Portugal	F/84	NPC/UNK	T4N2M0	+ +	+	n/a
7	Algeria	M/40	NPC/UNK	T4N2M0	+ +	-	+ (malpighian)
8	Turkey	M/57	NPC/UNK	T1N0M0	+ +	+	n/a
9	China	F/31	NPC/UNK	T4N0M0	+ +	-	- (malpighian)
10	France	M/48	NPC/UNK	T1N2M0	+ +	-	- (secretory)
11	France	M/62	Tonsil/Infiltrating SCC**	T2N1M0	+	+	- (malpighian)
12	France	F/82	Tongue/Differentiated SCC	T2N0M0	-	+	- (malpighian)
13	France	M/64	Pelvi-lingual furrow/Differentiated SCC	T2N1M0	-	+	- (malpighian)

* NPC/UNK : nasopharyngeal carcinoma/undifferentiated non-keratinizing, ** SCC : squamous cell carcinoma, ++ : intense and homogeneous galectin-9 staining, + : moderate or scattered galectin-9 staining, - : absence of galectin-9 staining, n/a : not applicable (no segment of non malignant mucosa observed in the tissue section).

ISSN: 1750-9378